Cannabis Science Company Profile (OTCMKTS:CBIS)

Analyst Ratings

Consensus Ratings for Cannabis Science (OTCMKTS:CBIS) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cannabis Science (OTCMKTS:CBIS)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cannabis Science (OTCMKTS:CBIS)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Cannabis Science (OTCMKTS:CBIS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cannabis Science (OTCMKTS:CBIS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cannabis Science (OTCMKTS:CBIS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/18/2016Robert James KaneCFOSell503,345$0.02$10,066.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2016Robert James KaneCFOSell300,000$0.02$6,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016Chad Steven JohnsonCOOSell500,000$0.02$10,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/29/2016Chad Steven JohnsonCOOSell2,402,000$0.02$48,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016Chad Steven JohnsonCOOSell483,852$0.02$9,677.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2016Chad Steven JohnsonCOOSell2,188,334$0.01$21,883.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/29/2016Chad Steven JohnsonCOOSell4,370,000$0.01$43,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2016Chad Steven JohnsonCOOSell1,765,300$0.01$17,653.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2015Chad Steven JohnsonCOOSell1,646,142$0.02$32,922.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2015Chad Steven JohnsonCOOSell769,986$0.02$15,399.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015Chad Steven JohnsonCOOSell1,852,239$0.02$37,044.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2015Chad Steven JohnsonCOOSell6,500,000$0.03$195,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Chad Steven JohnsonCOOSell1,063,575$0.03$31,907.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Chad Steven JohnsonCOOSell921,333$0.04$36,853.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Chad Steven JohnsonCOOSell1,400,000$0.04$56,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Chad Steven JohnsonCOOSell1,262,691$0.05$63,134.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2015Chad Steven JohnsonCOOSell1,809,914$0.06$108,594.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2015Chad Steven JohnsonCOOSell255,000$0.07$17,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2015Dh BrayCEOSell1,260,750$0.06$75,645.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Chad Steven JohnsonCOOSell1,600,000$0.07$112,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/20/2014Chad Steven JohnsonCOOSell433,990$0.07$30,379.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2014Chad Steven JohnsonCOOSell251,110$0.06$15,066.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Chad Steven JohnsonCOOSell400,000$0.09$36,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/31/2014Chad Steven JohnsonCOOSell750,000$0.08$60,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Robert MelamedeMajor ShareholderSell425,800$0.17$72,386.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Robert MelamedeMajor ShareholderSell779,200$0.19$148,048.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2014Robert MelamedeMajor ShareholderSell473,300$0.25$118,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014Robert MelamedeMajor ShareholderSell659,700$0.19$125,343.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2014Robert MelamedeMajor ShareholderSell600,200$0.19$114,038.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014Robert MelamedeMajor ShareholderSell525,000$0.14$73,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2014Robert MelamedeMajor ShareholderSell476,500$0.11$52,415.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014Robert MelamedeMajor ShareholderSell425,800$0.10$42,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Robert MelamedeMajor ShareholderSell248,800$0.12$29,856.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2014Robert MelamedeMajor ShareholderSell170,200$0.13$22,126.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Robert MelamedeMajor ShareholderSell132,200$0.07$9,254.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/3/2014Robert MelamedeMajor ShareholderSell83,300$0.07$5,831.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cannabis Science (OTCMKTS:CBIS)
DateHeadline
07/25/16 02:19 PMWill Cannabis Science Inc (OTCMKTS:CBIS) Stop Its Slide? - HotStocked
07/22/16 11:11 AMMedical Marijuana Stocks Are Set to Skyrocket in 2016 - Money Morning
07/21/16 07:02 AMCannabis Science 2016 Growth Guidance; Project Briefs, Cash-Flow Projections, and Current Historic Cannabis ... - SYS-CON Media (press release)
07/21/16 07:02 AMCANNABIS SCIENCE INCORPORATED (OTCMKTS:CBIS) Shorted Shares Increased 4256.92% After Market Selling - Consumer Eagle
07/20/16 07:45 AMCannabis Science 2016 Growth Guidance; Project Briefs, Cash-Flow Projections, and Current Historic Cannabis Industry Advancements; Industry Growth Indicators - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, is pleased to provide its future operations and growth guidance based on its current projects, cash-flow ...
07/19/16 03:08 PMCFA Announces That the 2016 Ronald H. Brown African Affairs Series Will Be a Bipartisan Forum to Develop Policy ...
07/18/16 03:17 PMCFA Announces That the 2016 Ronald H. Brown African Affairs Series Will Be a Bipartisan Forum to Develop Policy ... - Digital Journal
07/18/16 03:17 PMCannabis Science Inc's (CBIS) Sentiment is 0 - Press Telegraph
07/18/16 02:34 PMCFA Announces That the 2016 Ronald H. Brown African Affairs Series Will Be a Bipartisan Forum to Develop Policy Recommendations for the Next U.S. Presidential Administration - [Marketwired] - The Constituency for Africa today announced that its 2016 Ronald H. Brown African Affairs Series will be a bipartisan forum, and the outcome of this year's Series will be U.S.-Africa policy recommendations ...
07/18/16 08:08 AMTADALAFIL GENERIC - Buy Soft Cialis Online - Westerner
07/14/16 07:32 AMWhy Big Pharma May Push Back Against Legal Marijuana -
07/12/16 03:11 PMGENERIC VIAGRA - Best Canadian Prescription Prices - Arbitrage Magazine
07/12/16 07:20 AMCBIS CEO, Mr. Raymond C. Dabney, Invited to Serve as Co-Chair of the Constituency for Africa's 2016 Ronald H ... - Yahoo Finance
07/11/16 03:03 PMCBIS CEO, Mr. Raymond C. Dabney, Invited to Serve as Co-Chair of the Constituency for Africa's 2016 Ronald H. Brown African Affairs Series in September - [at noodls] - '2016 Ronald H. Brown African Affairs Series' by the Constituency for Africa (CFA), Scheduled September 12-17th in Washington, DC, 'Setting the US-Africa Agenda for the Next Administration' WASHINGTON, ...
07/11/16 07:55 AMGENERIC VIAGRA - Reputable Canadian Pharcharmy Online
07/08/16 03:06 PMCANADIAN PHARMACIES SHIPPING TO USA - Top 10 Mail Order Pharmacies
07/08/16 11:05 AMCannabis Companies Making Moves This Week - Seeking Alpha
07/08/16 07:39 AMCannabis Science-Sponsored "We Cann Mix - An Experience in Diversity" Deemed a Remarkable Success - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, partnered with The Joey Network to sponsor the "We Cann Mix - An Experience in Diversity" ...
07/03/16 07:46 AMCannabis Science Inc (OTCMKTS:CBIS) Continues To Recover - HotStocked
07/01/16 03:06 PMCannabis Science Inc (OTCMKTS:CBIS) Continues To Recover
07/01/16 02:08 PMCANNABIS SCIENCE, INC. Files SEC form 8-K, Other Events -
07/01/16 07:20 AMUPDATE - Cannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California. The company's ...
06/30/16 10:55 AMCannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles ... - Marketwired (press release)
06/30/16 07:21 AMCannabis Science Guidance; Corporate Headquarters Relocated to California as it Negotiates for a Los Angeles, California Laboratory/Medical Treatment Center - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, today announced the relocation of their corporate headquarters to Irvine, California. The company's ...
06/23/16 03:31 PMCannabis Science's Mieko Hester-Perez Confirms CBIS Premiere Sponsorship Role at "We Cann Mix," a Diverse ... - Marketwired (press release)
06/23/16 08:08 AMCannabis Science's Mieko Hester-Perez Confirms CBIS Premiere Sponsorship Role at "We Cann Mix," a Diverse Cannabis Community and Business Mixer Event in Los Angeles, CA - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, today announced their sponsorship of the "We Cann Mix" event, which is a mixer event intended ...
06/16/16 07:28 AMCannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles ... - Marketwired (press release)
06/16/16 07:06 AMCannabis Science Partners With FHP.TV & Kush Boys Studios to Host Its Black Tie, Red Carpet Event in Los Angeles; Coined, "Cannabis Kills Cancer," a Celebratory Fund Raiser - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicine, partners with FHP.TV & Kush Boys Studios to host its "black tie, red carpet" event in Los Angeles. ...
06/14/16 07:22 AMCannabis Science Inc (OTCMKTS:CBIS) Submits Its Quarterly Report - HotStocked
06/13/16 02:33 PMIt Is All Success For Cannabis Science Inc (OTCMKTS:CBIS) - Journal Transcript
06/13/16 11:03 AMCannabis Science Inc (OTCMKTS:CBIS) Submits Its Quarterly Report
06/11/16 11:16 AMCANNABIS SCIENCE INC
06/10/16 11:37 AMCannabis Science to Host Black Tie, Red Carpet Event in Los Angeles: "Cannabis Kills Cancer," a Celebratory ... - Marketwired (press release)
06/10/16 11:18 AMCannabis Science to Host Black Tie, Red Carpet Event in Los Angeles: "Cannabis Kills Cancer," a Celebratory Fundraiser Dinner Event for Celebrities, Scientists, Doctors, Patients, and Loyalty Shareholders Alike - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicine, to host "black tie, red carpet" event in Los Angeles. Company officials state the gala is a ...
06/09/16 04:14 PMCANNABIS SCIENCE, INC. Files SEC form 10-Q, Quarterly Report -
06/09/16 03:07 PMCANNABIS SCIENCE, INC. Files SEC form 10-K/A, Annual Report -
06/09/16 10:32 AMIs This Ginkgo Stock Better Than Marijuana Stocks? - SmallCap Network
06/07/16 08:44 PMCBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare ... - Marketwired (press release)
06/07/16 03:06 PMCBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare ... - Stockhouse
06/07/16 11:41 AMCBIS Delegation Completes Successful Trip to South Africa and Namibia and Launches Historic African Healthcare Initiative Led by Co-Founder, Mr. Raymond C. Dabney - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, announces the CBIS African healthcare infrastructure delegation led by Mr. Raymond Dabney and including ...
06/03/16 11:42 AMCBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant ... - Marketwired (press release)
06/02/16 11:51 AMCANNABIS SCIENCE INCORPORATED (OTCMKTS:CBIS) Sellers Covered 22.09% of Their Shorts - HNN - CANNABIS SCIENCE INCORPORATED (OTCMKTS:CBIS) Sellers Covered 22.09% of Their ShortsHNNAbout 7.04M shares traded hands. Cannabis Science Inc (OTCMKTS:CBIS) has declined 26.09% since October 23, 2015 and is downtrending. It has underperformed by 27.14% the S&P500. Cannabis Science, Inc. is engaged in medical marijuana research ...and more »
06/02/16 11:51 AMCBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant ... - Stockhouse - CBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant ...StockhouseNEUNKIRCHEN-RICHELBACH, GERMANY--(Marketwired - Jun 2, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, ...and more »
06/02/16 10:00 AMCBIS Subsidiary, Cannabis Science Europe GmbH, Releases World-First, Premium Quality, Cannabis Instant Beverage, Canna POW! - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, today announced Cannabis Science Europe GmbH, a European subsidiary of Cannabis Science Inc., based ...
05/31/16 03:08 PMCannabis Science Inc (OTCMKTS:CBIS) combines education and cannabis advocacy - Journal Transcript - Cannabis Science Inc (OTCMKTS:CBIS) combines education and cannabis advocacyJournal TranscriptCannabis Science Inc (OTCMKTS:CBIS) officials recently applauded the decision by the DEA to approve clinical trials to assess the effectiveness of smoked cannabis for the treatment of PTSD. According to CBIS, the move by DEA suggests that the agency is ...
03/14/16 01:39 PMCannabis Science Moves Forward Clinical Drug Development With Confidence as GW Pharma Announces Positive ... - Marketwired (press release) - New York TimesCannabis Science Moves Forward Clinical Drug Development With Confidence as GW Pharma Announces Positive ...Marketwired (press release)COLORADO SPRINGS, CO--(Marketwired - Mar 14, 2016) - Cannabis Science, Inc. ( OTC PINK : CBIS), a U.S. company specializing in the development of cannabis-based medicines, applauds the recent success of GW Pharmaceuticals in their phase three ...GWPharma - GW Pharmaceuticals Announces Positive Phase 3 Pivotal Study Results for Epidiolex® (cannabidiol)GW Pharmaceuticalsall 85 news articles »
03/14/16 12:43 PMCannabis Science Moves Forward Clinical Drug Development With Confidence as GW Pharma Announces Positive Results With Its CBD-Based Epilepsy Formulation - [Marketwired] - Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, applauds the recent success of GW Pharmaceuticals in their phase three testing of a CBD-based product ...
02/26/16 11:11 AMPurple Haze Properties (PHP) & Cannabis Science (CBIS) Announce Successful Launch of Hendrix-Themed Cannabis ... - Stockhouse - Proactive Investors USA & CanadaPurple Haze Properties (PHP) & Cannabis Science (CBIS) Announce Successful Launch of Hendrix-Themed Cannabis ...StockhouseLOS ANGELES, CA--(Marketwired - Feb 24, 2016) - Cannabis Science, Inc. ( OTC PINK : CBIS ), a U.S. company specializing in the development of cannabis-based medicines, is proud to announce Purple Haze Properties LLC ...Cannabis Science helps launch Jimi Hendrix-themed supplementsProactive Investors USA & Canadaall 6 news articles »
02/09/16 01:35 PMCannabis Science Inc (OTCMKTS:CBIS) Gears Up For Treating Autism - Journal Transcript - Journal TranscriptCannabis Science Inc (OTCMKTS:CBIS) Gears Up For Treating AutismJournal TranscriptIn a direction of extending coverage of cannabis-based medicines for treating new ailments, Cannabis Science Inc (OTCMKTS:CBIS) announced that it will develop a treatment for autism. To focus on its new objective, the company appointed Mieko ...Cannabis Science Inc (OTCMKTS:CBIS) Looking To BounceInsider FinancialCannabis Science Inc (OTCMKTS:CBIS) Appoints Mieko Hester-Perez To Lead Autism Treatment AdvocacyMMJ ObserverCANNABIS SCIENCE INCORPORATED (OTCMKTS:CBIS) Sellers Covered 15.9% of Their Shortsfdanewsalert.comCNNMoney -EIN News (press release)all 7 news articles »
02/09/16 08:02 AMCannabis Science, Inc. (OTCBB: CBIS) Partners With Purple Haze Properties - [Accesswire] - NEW YORK, NY / ACCESSWIRE / February 9, 2016 / Cannabis Science, Inc. (OTCBB: CBIS) after hitting their 52 week low last week, CBIS shares gained some momentum this week rising as much as 40% before settling ...

Social

About Cannabis Science

Cannabis Science, Inc. is engaged in medical marijuana research and development. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. The Company is involved in the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company focuses on the development of governmentally approved pharmaceuticals, including CS-TATI1, CS-S/BCC-1 and neurological therapy under study or development. The Company's subsidiaries include Cannabis Science BV and Cannabis Science International Holding BV.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: CBIS
  • CUSIP:
Key Metrics:
  • Previous Close: $0.01
  • 50 Day Moving Average: $0.0147
  • 200 Day Moving Average: $0.0153
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $24.78M
  • Current Year EPS Consensus Estimate: $N/A EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links:
Cannabis Science (OTCMKTS:CBIS) Chart for Monday, July, 25, 2016